https://www.contagionlive.com/view/janssen-s-rsv-protein-vaccine-candidate-proves-safe-and-effective-in-older-adults
The candidate, Ad26.RSV.preF–RSV preF protein vaccine, was 80.0% effective against severe disease and 69.8% effective against any RSV acute respiratory infection.
Create an account or login to join the discussion